πŸ‡ΊπŸ‡Έ FDA
Patent

US 11033516

Combination therapies with disulfiram

granted A61KA61K31/11A61K31/145

Quick answer

US patent 11033516 (Combination therapies with disulfiram) held by Spring Discovery, Inc. expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Spring Discovery, Inc.
Grant date
Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/11, A61K31/145, A61K39/39, A61P